HONG KONG,Feb. 27,2025-- Akeso,Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1,a
World NewsFeb 28, 2025Metabolon\'s expertise extends beyond metabolomics to include data insights and software solutions for multiomics research
World NewsFeb 28, 2025SHANGHAI,Feb. 28,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors
World NewsFeb 28, 2025AUCKLAND,New Zealand,Feb. 18,2025-- Kid-tech startup Polymath has secured $1M USD in funding with notable investment fromClassDojo CTO Liam Don in their first angel round,followed by a venture-backed
World NewsFeb 19, 2025HSINCHU,Feb. 18,2025-- Spirox Corporation (TWSE: 3055),a professional semiconductor equipment provider announced its plan to build the first power semiconductor dynamic reliability verification labora
World NewsFeb 19, 2025English Morning News: Your Source for Regional News and Corporate
© English Morning News
Privacy Policy